This document describes the step-by-step process for planning stereotactic radiotherapy for a brain metastasis case. It involves clinical evaluation, imaging with MRI and PET-CT, target and organ-at-risk delineation on the planning CT fused with MRI, planning with VMAT technique, and evaluation of the plan based on target coverage, organ-at-risk doses and conformity/homogeneity indices. The case presented is of a 70-year old female breast cancer patient with a solitary 2.2 cm left occipital brain metastasis planned to receive a single 18 Gy fraction stereotactic radiosurgery treatment based on her prognosis and age.
This presentation is intended to refer while doing planning of SBRT Prostate for all practical aspects from Simulation - contouring - planning - treatment. I am sure it will be very useful presentation for any radiation oncologist who are willing to start workflow of SBRT Prostate in the department of radiation oncology
This presentation is intended to refer while doing planning of SBRT Prostate for all practical aspects from Simulation - contouring - planning - treatment. I am sure it will be very useful presentation for any radiation oncologist who are willing to start workflow of SBRT Prostate in the department of radiation oncology
Quality Assurance in Radiotherapy. Web-based quality assurance; using medical web instrument to facilitate the education, collaboration and peer review, providing an environment in which clinical investigators can receive, share and analyse treatment planning digital data.
This is a made easy summary of ICRU 89 guidelines for gynecological brachytherapy. Extra practical questions for MD/DNB Radiotherapy exams are also attached.
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXVictor Ekpo
TPR(20,10) is the recommended photon beam quality index by IAEA TRS-398 for megavoltage clinical photons generated by linear accelerators. This presentation goes through the basics of Tissue Phantom Ratio (TPR).
Quality Assurance in Radiotherapy. Web-based quality assurance; using medical web instrument to facilitate the education, collaboration and peer review, providing an environment in which clinical investigators can receive, share and analyse treatment planning digital data.
This is a made easy summary of ICRU 89 guidelines for gynecological brachytherapy. Extra practical questions for MD/DNB Radiotherapy exams are also attached.
TISSUE PHANTOM RATIO - THE PHOTON BEAM QUALITY INDEXVictor Ekpo
TPR(20,10) is the recommended photon beam quality index by IAEA TRS-398 for megavoltage clinical photons generated by linear accelerators. This presentation goes through the basics of Tissue Phantom Ratio (TPR).
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...Enrique Moreno Gonzalez
To present our experience of intensity-modulated radiotherapy (IMRT) with simultaneous modulated accelerated radiotherapy (SMART) boost technique in patients with nasopharyngeal carcinoma (NPC).
Breast conserving surgery followed by adjuvant radiotherapy is adopted in the early detected cases and mastectomy followed by radiotherapy or chemotherapy in the advanced cases are the general practices.
Comparative dosimetry of forward and inverse treatment planning for Intensity...iosrjce
IOSR Journal of Applied Physics (IOSR-JAP) is a double blind peer reviewed International Journal that provides rapid publication (within a month) of articles in all areas of physics and its applications. The journal welcomes publications of high quality papers on theoretical developments and practical applications in applied physics. Original research papers, state-of-the-art reviews, and high quality technical notes are invited for publications.
Stereotactic Radiosurgery and Radiotherapy of Brain Metastases Clinical White...Brainlab
Learn more: https://www.brainlab.com/iplan-rt
Brain metastases are a common manifestation of systemic cancer constituting as much as 30% of all intracranial malignant tumors. Each year, 15 to 30% of cancer patients develop brain metastases, yielding an incidence of over 100,000 patients in the US. Development of brain metastases leads directly to the patient’s death in the majority of cases.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. 2 Journal of Current Oncology
takes into account various factors such as primary tumor type,
molecular profile of tumor, and number of brain metastasis. It
helps the physician as well as the patient to choose the
appropriate treatment.
In the current case, details of patient such as age of
patient at the time of diagnosis of brain metastasis,
Karnofsky Performance Status of the patient, number of
brain metastasis, tumor type, and molecular subtype were
used to calculate the GPA to be 1.5 with median survival
of 7.7 months.
Treatment Decision by the Tumor Board
The patient details were put in the tumor board for decision
regarding the line to treatment. After group discussion with
neurosurgeon, radiation oncologist, and medical oncologist,
board decided to plan for stereotactic radiosurgery followed
by chemotherapy.
Treatment Decision by the Radiation
Tumor Board
TNBC being an aggressive histology, a TNBC patient with
brain metastasis would benefit from whole brain radiation
with simultaneous integrated boost to the solitary lesion. But
basing on the advanced age of the patient, ie 70 years, and in
order to prevent development of radiation induced
neurological toxicity and deterioration of quality of life, the
radiation tumor board opined for SRS. In the present case,
there was a single brain metastasis of diameter 2.2 cm, the
radiation tumor board decided for single fraction SRS with 18
Gy marginal dose as per RTOG 9005.3
RT Planning
Here we describe the steps of treatment of brain metastasis
from simulation to plan execution
Step 1: CT Simulation
During simulation, patient was set up in the supine
position with neutral neck position and immobilization
was done using FRAXION thermoplastic mask and
stereotactic frame with mouth bite (Figure 2a). Fiducials
were placed on the thermoplastic mask after proper
alignment with the lasers. Intravenous contrast was given
at a dose of 1 mL per kg body weight. Then, CT scan was
taken from the vertex to neck with CT slice thickness of
1 mm as is depicted in Table 1 (Figure 2b). After
simulation, the DICOM CT, images were sent to our
Oncentra server which was then imported for delineation
of target and organ at risk (OAR).
Figure 1. MRI Images of Patient With Single Lesion at the Left
Occipital Region With Ring Enhancement and Minimal Edema.
Table 1. Showing CT Simulation and MRI Protocol to Be Followed
for Brain Metastasis.
CT Simulation Protocols for Simulation
Supine position
Immobilization using stereotactic thermoplastic mask
Intravenous contrast at a rate of 1 mg/kg
CT scan taken from vertex to neck 15 minutes after contrast
administration
1 mm slice thickness
MRI Protocol Utility
T1/T2/FLAIR sequence Usual sequence
3D FSPGR sequence Normal anatomy
512 × 512 matrix
1 mm slice thickness
No gap
No tilt
Neutral neck
Figure 2. Immobilization of the Patient Using the Stereotactic
Thermoplastic Mask and Frame During CT Simulation in (2a), the
Planning CT Scan in (2b), and Fusion of MRI of the Patient With
Planning CT Scan in (2c).
3. Patro et al. 3
Step 2: MRI Protocol
MRI of brain of the patient was done using 512 × 512 matrix in the
neutral neck position similar to that of CT scan during simulation
with no gap, no tilt, and 1 mm slice thickness as depicted in
Table 1. The MRI should include the usual T1, T2, FLAIR
sequences. In addition, the 3D FSPGR was used to view the
normal anatomy.4 If dedicated MR simulator is available, MR
simulationcanbedoneusingthis MRIprotocolandthesimulation
process being same as the CT simulation mentioned above.
Step 3: Image Fusion
This acquired MRI sequences were fused with the planning CT
scan by contouring the eyes, lens, basilar artery, sinuses, and
calcification and matching was done using the auto-fusion
technique to help in target and OAR delineation (Figure 2c).
Step 4: Target Delineation
The gross tumor seen on the CT images that was fused with
the MRI images to consider the exact extension of tumor was
delineated as Gross Tumor Volume (GTV) (Figures 3a,b).
There is no necessity of Clinical Target Volume margin in
case of SRS brain metastasis. The Planning Target Volume
(PTV) was drawn taking 1 mm around the GTV (Figure 3c).
Smoothing of the contour was done from the adjacent bone.
Multi-planar evaluation, ie evaluation of both the GTV and
PTV, were done in all the three planes—axial, coronal, and
sagittal.
In the present case, the GTV volume was 4.65 cc and the
PTV volume was 5.75 cc.
Step 5: Organs at Risk (OAR) Delineation
The OARs for delineation included both the cochlea,
brainstem, hippocampus, optic chiasma, and optic apparatus.
The cochlea was contoured in the bone window setting while
other OARs, ie brainstem, hippocampus, optic chiasma, and
optic apparatus, were contoured using the MRI that was fused
with the planning CT. Also Brain-GTV was also drawn as an
OAR (Figure 4a).
Step 6: RT Technique
Radiation planning can be done using any of the RTtechniques
such as Intensity Modulated Radiotherapy (IMRT),
Volumetric Modulated Arc Therapy (VMAT), Dynamic
Conformal Arc Therapy (DCARC), or 3-Dimensional
Conformal Radiotherapy (3DCRT) according to convenience
of radiation physicist and physician.
In the present case planning was done using the VMAT
technique.
Step 7: Plan Evaluation
After the completion of planning by the physicist, the
evaluation for the treatment plan was done using the following
indices.
PTV Coverage Index
Following planning, the coverage of the PTV need to be seen.
The prescription isodose level was such that not 100% of
the prescribed dose covered 100% of the PTV. Often 95% of
the prescription dose covered 95% or higher percentage of the
PTV, otherwise 100% of the prescription dose covered 95%
or higher percentage of the PTV.5
In the present case, 95% of the prescription dose covered
99.9% of the PTV and 100% of the prescription dose
covered 99.15% of the PTV which satisfied the above-
mentioned parameter for the PTV coverage as depicted in
the Table 2.
Intracranial Organ at Risk (OAR) Index
Keeping in mind the desirable dose constraints to the OAR
we need to check the dose to individual OARs.6
Figure 3. The Delineation of GTV (Pink) in Planning CT Is Shown in 3a, Delineation of GTV (Pink) in MRI Is Shown in 3b and PTV (Cyan)
Is Generated by Taking 1 mm Margin Around GTV Shown in 3c.
4. 4 Journal of Current Oncology
The dose desirable and dose achieved for all the OARs in
the present case is depicted in Table 3.
Whole Brain-GTV Dose
Korytko et al have stated that while treating Non-AVM
tumors with Gamma Knife, in order to reduce the risk of
symptomatic radiation induced necrosis of brain, the dose to
12 Gy volume of Brain-GTV should be limited to <10 cc.7
This data can be extrapolated while treating patients with
single fraction SRS.
In the current case, the 12 Gy volume of Brain-GTV was
10.765 cc.
Conformity Index: To note the conformity index of the
SRS, here we used 2 types of conformity indices, ie the
RTOG conformity index and the Paddick conformity
index.5,8
RTOG Conformity index (CIRTOG) was calculated using
the following formula.
CIRTOG = Volume of prescription isodose / PTV volume
In this case of VS, the RTOG conformity index was 1.18
(Table 2).
Paddick conformity index (CIPaddick) was calculated
using the following formula:
CIPaddick = (Volume of prescription isodose in the area of
interest ie PTV)2 / PTVvolume ×Volume of prescription isodose
Here in the current case, the Paddick conformity index
was 0.82 (Table 2).
Homogeneity Index
It was calculated using the formula:
Homogeneity index = Maximum dose / Prescription dose
In this case the homogeneity index was 1.27 (Table 2).
Dose Fall Off
The dose fall off observation is very much needed in the plan
evaluation under the heading of gradient index. For this we
need to calculate the difference between various isodose
lines. In order to calculate the difference between the isodose
lines we need to calculate the equivalent radius.
Equivalent Radius Calculation
To evaluate the dose gradient, we have to find out the
difference between radius of various isodose lines. But none
of the isodoses are spherical. So, we use the following formula
to calculate the equivalent radius.
Figure 4. Showing the Brain-GTV in 4a and Beam Arrangement in Axial (4b), Cronal (4c), and Sagittal View (4d).
5. Patro et al. 5
Table 3. Organs at Risk With Their Desirable Dose and Dose Achieved in the Current Case.
Organ Desirable Dose Achieved Dose
Right eye DMax < 8 Gy <1 Gy
Left eye DMax < 8 Gy <1 Gy
Right optic nerve DMax < 8 Gy <1 Gy
Left optic nerve DMax < 8 Gy <1 Gy
Optic chiasma DMax < 8 Gy 1.88 Gy
Left hippocampus 5 Gy
Right hippocampus 9 Gy
Brain stem DMax < 8 Gy 3.83 Gy
Right cochlea DMean < 9 Gy <1 Gy
Left cochlea DMean < 9 Gy <1 Gy
Table 2. The Various Indices of Plan Evaluation of Brain Metastasis in the Current Case.
Parameter Value Desirable
Dmax 22.89 Gy –
D95% 18.82 Gy –
D100% 16.62 Gy –
V95% 99.93% –
V25Gy (V100%) 99.15% –
V110% 81.01% –
V120% 17.97% –
V130% 0 –
PTV volume 5.755 cc –
Volume of prescription isodose 6.811 cc –
Volume of prescription isodose within the
PTV
5.706 cc –
Maximum dose 22.89 Gy –
Prescription dose 18 Gy –
RTOG conformity index 1.18 1–2
Paddick conformity index 0.82 0.85–1
Homogeneity index 1.27 1.1-1.3
Parameter Volume Radius
100% isodose line 6.811 cc 1.18 mm
80% isodose line 11.00 cc 1.38 mm
60% isodose line 17.14 cc 1.6 mm
50% isodose line 22.05 cc 1.74 mm
40% isodose line 30.09 cc 1.93 mm
First: Find out the specified isodose volume
Second: Calculate the radius of the isodose volume by
using the formula:
V = 4/3 π r3
r = (3V/4 π)1/3
The calculation of volume and radius of various isodose
lines in the present case is shown in Table 2.
Gradient Index
The formula for calculating gradient index is as follows.
6. 6 Journal of Current Oncology
Gradient index = Equivalent radius of 50% isodose –
Equivalent radius of prescription isodose. Ideally the gradient
index should be between 0.3 mm and 0.9 mm.
In the current case, the gradient index was 1.74 mm – 1.18
mm = 0.56 mm which was close to ideal gradient index.
Gradient index can also be calculated as the ratio of
the volume enclosed by half of the prescription isodose
divided by the prescription isodose volume. The ideal
value is < 3.5
In the present case, the gradient index was calculated by
9 Gy volume / 18 Gy volume, ie 22.2/6.8 = 3.2.
Distance BetweenVarious Isodose Lines
The ideal difference between 80% and 60% isodose lines
should be < 2 mm.9
In the current case it was 0.22 mm.
The ideal difference between 80% and 40% isodose lines
should be < 8 mm.
In present case, it was 0.55 mm.
Beam Arrangement
The arrangement of the beams (Figures 4b-d) was done such
that there is adequate coverage of the target while giving less
dose to the OARs. It should be noted that the beams should
not pass through the ipsilateral eye.
Step 8: Quality Assurance (QA)
Mechanical isocenter check was done using the Winston Lutz
test and the point dose verification was done keeping the
tolerance as 1 mm.10
Step 9: Dry Run
Treatment verification consists of setup reproduction,
isocenter verification, and clinically verifying each treatment
field—check beam clearance, check any interlock—MLC
interlock and potential monitor unit problems. Then clearly
mark the immobilization devices after successful dry run.
Step 10: Premedication Protocol
Prior to start of treatment premedication was delivered in the
form of tablets as described further—all starting the day
before start of RT treatment:
Tablet Dexamethasone 8 mg—thrice daily
Tablet Ondansetron 8 mg—thrice daily
Tablet pantoprazole 40 mg—once daily
If the patient is diabetic, proper diabetic care needs to be done.
Step 11: Set up Verification and Treatment Delivery
It includes cone beam CT correction (Figures 5a-c) and
hexapod corrections (Figure 5d). After all the corrections
been done treatment was delivered.
Step 12: Post Medication
It is an optional protocol that usually includes anti emetics, proton
pump inhibitors, and tapering the dose of steroid over a week.
We also provide the Brain Metastasis SRS Plan Evaluation
sheet as a supplementary file that will help in proper and
accurate plan evaluation for every SRS case of brain
metastasis.
Figure 5. Depicting the Treatment Verification by CBCT Correction of the Patient During the Treatment in Coronal (5a), Sagittal View
and (5b), Axial (5c), and the Hexapod Correction of the Same Patient During the Treatment in 5d.
7. Patro et al. 7
Conclusion
This paper conceptualizes and acts as an easy guide for the
beginners for the stereotactic radiation planning for brain
metastasis.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to
the research, authorship, and/or publication of this article.
Funding
The authors received no financial support for the research,
authorship, and/or publication of this article.
Statement of Informed Consent and Ethical
Approval
Necessary ethical clearances and informed consent was received and
obtained respectively before initiating the study from all participants.
Appendix
BRAIN METASTASIS SRS PLAN EVALUATION CHECK LIST
1. NAME UMR
2. DIAGNOSIS
3. PRIOR TREATMENT
4. DISEASE SPECIFIC GRADED PROGNOSTIC ASSESSMENT SURVIVAL
5. PRIOR WBRT YES NO DOSE INTERVAL
6. PRIOR SRS YES NO DOSE INTERVAL
7. NUMBER OF METASTASIS/CAVITY
8. LOCATION SIDE SIZE max [mm] PTV MARGIN VOLUME-CC DOSE
1. GTV PTV
2. GTV PTV
3. GTV PTV
4. GTV PTV
5. GTV PTV
9. PLAN TYPE-[3DCRT/VMAT/DCR/IMRS]
10. PRESCRIBED MARGINAL ISODOSE
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
D MAX LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
D95% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
D100% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
V95% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
V100% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
V120% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
V130% LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
DISTANCE BETWEEN 80% ISODOSE AND 60% ISODOSE-[<2mm]
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
DISTANCE BETWEEN 80% ISODOSE AND 40% ISODOSE-[<8mm]
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
CONFIRMITY INDEX [IDEAL 1]VOLUME OF PRESCRIPTION ISODOSE/VOLUME OF PTV
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
HOMOGENITY INDEX [BETWEEN 1.1-1.3] MAX DOSE/ PRESCRIPTION DOSE
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
(Appendix continued)
8. 8 Journal of Current Oncology
BRAIN METASTASIS SRS PLAN EVALUATION CHECK LIST
GRADIENT INDEX[BETWEEN 0.3-0.9][RADIUS OF PRESCRIPTION ISODOSE - RADIUS OF HALF
PRESCRIPTION ISODOSE]
LESION 1 LESION 2 LESION 3 LESION 4 LESION 5
11. 1. BRAIN-GTV[12Gy volume] <10cc and D50% <5Gy
2. BRAIN-GTV[4Gy volume] <20CC-MULTIPLE FRACTION
12. OAR SINGLE FRACTION 5 FRACT. [ALT. DAY] ACHIEVED
1. RIGHT EYE MAX<8Gy MAX <22.5Gy
2. LEFT EYE MAX<8Gy MAX <22.5Gy
3. RIGHT OPTIC NERVE MAX<8Gy MAX <22.5Gy
4. LEFT OPTIC NERVE MAX<8Gy MAX <22.5Gy
5. OPTIC CHIASM MAX<8Gy MAX <22.5Gy
6. BRAIN STEM MAX <15Gy MAX <31Gy
7. RT.HIPPOCAMPUS
8. LT.HIPPOCAMPUS
9. RT.COCHLEA MEAN <9Gy MEAN <25Gy
10. LT.COCHLEA MEAN <9Gy MEAN <25Gy
(Appendix continued)
References
1. Lin X, DeAngelis LM. Treatment of brain metastases. J Clin
Oncol. 2015; 33:3475-3484.
2. Brain metastases Prognostic Index. https://qxmd.com/calculate/
calculator_357/brain-metastases-prognostic-index. Accessed
Dec 29, 2022.
3. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgi-
cal treatment of recurrent previously irradiated primary brain
tumors and brain metastases: final report of RTOG protocol
90-05. Int J Radiat Oncol Biol Phys. 2000; 47:291-298.
4. Metcalfe P, Liney GP, Holloway L, et al. The potential for an
enhanced role for MRI in radiation-therapy treatment planning.
Technol Cancer Res Treat. 2013; 12:429-446.
5. Torrens M, Chung C, Chung H, et al. Standardization of
terminology in stereotactic radiosurgery: report from the
Standardization Committee of the International Leksell
Gamma Knife Society: special topic. J Neurosurg. 2014;
121(Suppl_2):2-15.
6. Hanna GG, Murray L, Patel R , et al. UK Consensus on Normal
Tissue Dose Constraints for Stereotactic Radiotherapy. Clin
Oncol (R Coll Radiol). 2018;30:5-14.
7. Korytko T, Radivoyevitch T, Colussi V, et al. 12 Gy gamma knife
radiosurgicalvolumeisapredictorforradiationnecrosisinnon-AVM
intracranial tumors. Int J Radiat Oncol Biol Phys. 2006;64:419-424.
8. Petkovska S, Tolevska C, Kraleva S, Petreska E. Conformity
index for brain cancer patients. Proceedings of the Second
Conference on Medical Physics and Biomedical Engineering of
R Macedonia. Macedonia, The Former Yugoslav Republic of:
Association for Medical Physics and Biomedical Engineering
of R Macedonia; 2010;43:111.
9. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-
brain radiotherapy versus observation after radiosurgery or sur-
gical resection of one to three cerebral metastases: results of the
EORTC 22952-26001 study. J Clin Oncol. 2011;29:134-141.
10. Denton TR, Shields LB, Howe JN, Spalding AC. Quantifying
isocenter measurements to establish clinically meaningful
thresholds. J Appl Clin Med Phys. 2015;16:5183.